Microbot Medical (MBOT) Cash from Investing Activities (2010 - 2026)

Microbot Medical's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at $5.0 million for Q1 2026.

• Quarterly Cash from Investing Activities rose 120.12% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$42.6 million (down 93.36% YoY) and the FY2025 annual result came in at -$72.4 million, down 4809.43% from the prior year.
• Cash from Investing Activities was $5.0 million for Q1 2026 at Microbot Medical, up from -$1.5 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $5.0 million in Q1 2026 and bottomed at -$44.7 million in Q3 2025.
• A 5-year average of -$4.0 million and a median of -$62000.0 in 2022 frame the typical range for Cash from Investing Activities.
• Peak annual rise in Cash from Investing Activities reached 18118.75% in 2023, while the deepest fall reached 51340.0% in 2023.
• Microbot Medical's Cash from Investing Activities stood at -$3.8 million in 2022, then surged by 178.79% to $3.0 million in 2023, then plunged by 49.44% to $1.5 million in 2024, then sank by 202.54% to -$1.5 million in 2025, then soared by 425.96% to $5.0 million in 2026.
• Business Quant data shows MBOT's Cash from Investing Activities at $5.0 million in Q1 2026, -$1.5 million in Q4 2025, and -$44.7 million in Q3 2025.